Cite
APA Citation
Yoshikawa, A., Kawamoto, Y., Yuki, S., Nakano, S., Sawada, K., Muranaka, T., Nakatsumi, H., Harada, K., Kobayashi, Y., Miyagishima, T., Saiki, T., Ishiguro, A., Saito, R., Ehira, N., Iwanaga, I., Hatanaka, K., Abe, N., Sakamoto, N., Sakata, Y., & Komatsu, Y. (n.d.). 196PHGCSG1403: Phase I trial of oxaliplatin/irinotecan/S-1 (OX-IRIS) as first-line chemotherapy for unresectable pancreatic cancer. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095320644.0x00003e